Filter
9083
Filtered Results: 9083
Text search:
national
health
programme
Featured
Recommendations
732
New Publications
2439
Language
Document type
No document type
5027
Studies & Reports
1597
Guidelines
1068
Manuals
517
Strategic & Response Plan
404
Training Material
153
Fact sheets
140
Situation Updates
86
Infographics
38
Resource Platforms
24
Brochures
20
Online Courses
9
Countries / Regions
India
432
Global
389
Kenya
258
South Africa
197
Nepal
176
Sierra Leone
167
Nigeria
165
Uganda
156
Ethiopia
154
Western and Central Europe
149
Myanmar / Burma
147
Congo, Democratic Republic of
137
Senegal
135
Tanzania
133
Africa
129
Zambia
129
Malawi
127
Bangladesh
115
Ghana
114
Liberia
112
Rwanda
95
Syria
94
Namibia
88
Ukraine
86
Burkina Faso
84
Latin America and the Carribbean
84
Benin
69
South Sudan
67
Eastern Europe
66
Haiti
65
Lesotho
61
Zimbabwe
58
South–East Asia Region
57
Asia
56
Cameroon
55
Guinea
55
Indonesia
49
Mozambique
47
Cambodia
46
Philippines
44
Botswana
41
Madagascar
41
West and Central Africa
39
East and Southern Africa
35
Yemen
34
Central African Republic
32
Pakistan
30
Germany
28
Middle East and North Africa
27
Brazil
27
Russia
27
Mali
27
Eswatini/ Swaziland
27
Afghanistan
26
Venezuela
26
Colombia
25
Eastern Europe and Central Asia
23
Sudan
21
Somalia
21
Jordan
20
Lebanon
20
Togo
19
Niger
18
Western Pacific Region
18
Tajikistan
17
Vietnam
16
Thailand
15
Côte d’Ivoire / Ivory Coast
15
Sri Lanka
15
Iraq
14
China
13
Laos
13
Paraguay
13
Albania
11
Peru
11
Moldova
11
North Macedonia
9
Kyrgyzstan
9
Argentina
9
Georgia
9
Chad
9
Burundi
8
Turkey
7
Angola
7
Gambia
6
Kazakhstan
6
Iran
6
Armenia
6
Jamaica
6
Southern Africa
6
Palestine
6
Libya
6
Ecuador
6
Timor Leste/ East Timor
5
Chile
5
Guinea-Bissau
5
El Salvador
4
Serbia
4
Morocco
4
Hungary
4
Turkmenistan
4
United Kingdom
4
Bolivia
4
Poland
4
Bhutan
4
Mexico
3
Singapore
3
Estonia
3
Mauritania
3
USA
3
France
3
Mauritius
3
Tunisia
3
Portugal
3
Spain
3
Bosnia and Herzegovina
3
Papua New Guinea
3
Egypt
3
Romania
3
Greece
3
Honduras
3
Guatemala
3
Fiji
2
Congo-Brazzaville
2
Uzbekistan
2
Malaysia
2
Qatar
2
Bulgaria
2
Italy
2
Croatia
2
Ireland
2
Saudi Arabia
2
North America
2
Japan
2
Azerbaijan
2
Belarus
2
Nicaragua
2
Djibouti
2
Slovakia
2
North Korea
1
Switzerland
1
Canada
1
Austria
1
Mongolia
1
Lithuania
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Algeria
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3570
Clinical Guidelines
599
Key Resources
537
Public Health
484
Women & Child Health
484
Capacity Building
136
Pharmacy & Technologies
93
Toolboxes
HIV
766
COVID-19
595
Mental Health
560
TB
516
Disability
376
Planetary Health
324
NTDs
266
Caregiver
256
Conflict
250
AMR
231
Rapid Response
230
Ebola & Marburg
220
Global Health Education
168
Refugee
160
NCDs
155
Malaria
148
Pharmacy
128
Natural Hazards
111
Health Financing Toolbox
106
2.0 Rapid Response
86
Polio
54
Zika
44
Specific Hazards
36
Cholera
35
Social Ethics
19
Typhoon
7
South Sudan
2
People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19 pandemic. The Information note on HIV and COVID-19 addresses common concerns people living with HIV have rega...
This Birth Defect Surveillance facilitator (train-the-trainer) guide 2nd edition covers foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomaly surveillance programme, whether population-based or hospital-based, in particular for countries ...
This document aims to provide guidance to countries in the identification of priority areas
for intervention as part of the Situational Analysis of their National Cholera Control or
Elimination Plans (NCPs).
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
A manual for impact assessments. The SCH Practical and Precision Assessment (SPPA) strategy is an evidence-based approach for conducting impact assessments for SCH. The SPPA was identified by programme managers and SCH experts from the African region as a feasible and sufficiently accurate approach ...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
Weekly epidemiological record 18 July 2025
This report summarizes application of the SAFE strategy against trachoma during 2024. It includes estimates of the global population at risk of trachoma blindness based on district-by-district data submitted to WHO by national programmes.
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
Policy brief. HIV testing services (HTS) and anti-retroviral therapy (ART) have been scaled up substantially. It is estimated that, globally, nearly 80% of people with HIV now know their status. With the offer of immediate ART initiation and improved treatment options, access to and uptake of treatm...
Weekly Epidemiological Record. This report summarizes application of the SAFE strategy against trachoma during 2023. It includes estimates of the global population at risk of trachoma blindness based on district-by-district data submitted to WHO by national programmes. Summarizing the epidemiologica...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks
recommended
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the...
The Blueprint is intended to guide programming, resource allocation, and commitments to achieve the national objective of a contraceptive prevalence rate (CPR) of 36 percent by 2018.
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
Cada año, más de 700.000 personas pierden la vida por suicidio, la cuarta causa principal de mortalidad entre las personas de 15 a 29 años y la tercera entre las niñas de 15 a 19 años. La reducción de la tasa mundial de mortalidad por suicidio en un tercio para el 2030 es un indicador de los O...
The Newborn Situational Analysis reports of 2009 and 2011, as well as the “Bottleneck analysis on neonatal health” of 2013, culminated in the Nigeria launch of “Call to action on Newborn health” at the first National Newborn Health Conference in 2014. This call to action provided the framewo...
